Lapiz, Gemilyn B.

HRN: 21-51-55  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2022
CEFUROXIME 500MG (TAB)
06/29/2022
07/06/2022
PO
500mg
BID X 7 Days
Wbc: 17.8; Post-op
Waiting Final Action 

Indication:  Empirical De-escalation    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: